Peptide and Protein Vaccines

— —

Rossen Donev (Head of Research, MicroPharm Limited, UK) Rossen Delete Donev (Swansea University, UK)

Peptide and Protein Vaccines

Rossen Donev (Head of Research, MicroPharm Limited, UK), Rossen Delete Donev (Swansea University, UK), Rossen Delete Donev (Swansea University, UK) , Rossen Delete Donev (Swansea University, UK)

$217.95

Hardback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We then advise you accordingly. If the time taken to get any book is too long for you, you can let us know and we will cancel or adjust your order, and refund as required.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

Academic Press Inc
05 June 2015

Xenobiotics; Proteins; Molecular biology; Cellular biology (cytology)

Published continuously since 1944, the Advances in Protein Chemistry and Structural Biology series has been the essential resource for protein chemists. Each volume brings forth new information about protocols and analysis of proteins. Each thematically organized volume is guest edited by leading experts in a broad range of protein-related topics.

By: Rossen Donev (Head of Research MicroPharm Limited UK), Rossen Delete Donev (Swansea University, UK), Rossen Delete Donev (Swansea University, UK), Rossen Delete Donev (Swansea University, UK)
Imprint: Academic Press Inc
Country of Publication: United States
Volume: 99
Dimensions: Height: 229mm, Width: 151mm, Spine: 15mm
Weight: 390g
ISBN: 9780128028278
ISBN 10: 0128028270
Pages: 192
Publication Date: 05 June 2015
Audience: Professional and scholarly , Undergraduate
Format: Hardback
Publisher's Status: Active

Peptide Immunotherapy in Vaccine Development: from Epitope to AdjuvantHyun Yang and Dong Seok Kim The use of liposomes to shape epitope structure and modulate immunogenic responses of peptide vaccines against HIV MPER.Beatriz Apellániz and José L. Nieva Recombinant Lipoproteins as Novel Vaccines with Intrinsic AdjuvantPele Chong, Jui-Hsin Huang, Chih-Hsiang Leng, Shih-Jen Liu and Hsin-Wei Chen Chemical Platforms for Peptide Vaccine ConstructsSuhas Ramesh, Prabhakar Cherkupally, Thavendran Govender, Hendrik G. Kruger, Fernando Albericio and Beatriz G. de la Torre Understanding Amino Acid Mutations in Hepatitis B Virus Proteins for Rational Design of Vaccines and DrugsKe Shen, Li Shen, Jing Wang, Zhi Jiang and Bairong Shens Perspective of peptide vaccine composed of epitope peptide, CpG-DNA, and liposome complex without carriersYounghee Lee, Young Seek Lee, Sooyoung Cho and Hyung-Joo Kwon

Rossen Donev received his PhD degree in 1999 from the Institute of Molecular Biology, Bulgarian Academy of Sciences. He did postdoctoral training at Imperial Cancer Research Fund, UK (renamed after the merger with Cancer Research Campaign to Cancer Research UK, London Research Institute) and Cardiff University. In 2007 he was awarded a New Investigator Grant Award from the Medical Research Council (UK) to establish himself as an independent Principle Investigator. In 2010 Dr. Donev was appointed Senior Lecturer at Swansea University. In 2016 Dr. Donev joined MicroPharm Ltd (UK) where currently he is Head of Research. He has published more than 60 research papers, chaired scientific meetings and given invited plenary talks. Rossen Donev has consulted on projects related to development of treatments for neurodevelopmental disorders and cancer therapies. He serves as Editor-in-Chief of the Advances in Protein Chemistry and Structural Biology and on editorial board of several other journals. His research interests include signaling pathways involved in neuropsychiatric disorders and tumor escape from the immune system, and development of therapeutic strategies for their treatment. More recently he has focused on development of immunotherapeutics for non-systemic applications.